TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ARA Life Science AB
Closing information (x1000 DKK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
113
|
120
|
111 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
99
|
101
|
99 |
| EBITDA |
99
|
101
|
100 |
| Total assets |
194
|
212
|
218 |
| Current assets |
194
|
212
|
218 |
| Current liabilities |
47
|
58
|
62 |
| Equity capital |
147
|
154
|
156 |
| - share capital |
66
|
72
|
73 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
75.8%
|
72.6%
|
71.6% |
| Turnover per employee |
56
|
60
|
56 |
| Profit as a percentage of turnover |
87.6%
|
84.2%
|
89.2% |
| Return on assets (ROA) |
51.0%
|
47.6%
|
45.9% |
| Current ratio |
412.8%
|
365.5%
|
351.6% |
| Return on equity (ROE) |
67.3%
|
65.6%
|
63.5% |
| Change turnover |
3
|
10
|
8 |
| Change turnover % |
3%
|
9%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.